Attached files
| file | filename |
|---|---|
| EX-32 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - Monopar Therapeutics | exhibit32-1.htm |
| EX-31 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - Monopar Therapeutics | exhibit31-2.htm |
| EX-31 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - Monopar Therapeutics | exhibit31-1.htm |
| EX-23 - CONSENTS OF EXPERTS AND COUNSEL - Monopar Therapeutics | exhibit23-1.htm |
| EX-10 - MATERIAL CONTRACTS - Monopar Therapeutics | exhibit10_12prx2019consag.htm |
| EX-10 - MATERIAL CONTRACTS - Monopar Therapeutics | exhibit10_11iso.htm |
| EX-10 - MATERIAL CONTRACTS - Monopar Therapeutics | exhibit10_10nq.htm |
| EX-4 - INSTRUMENTS DEFINING THE RIGHTS OF SECURITY HOLDERS, INCLUDING INDENTURES INSTRU - Monopar Therapeutics | exhibit4-1.htm |
| 10-K - PRIMARY DOCUMENT - Monopar Therapeutics | mnpr_10k2019.htm |
Exhibit 21.1
Subsidiaries of Monopar Therapeutics Inc. as of December 31,
2019
|
Name
|
|
Direct Parent
|
|
Ownership
|
|
Jurisdiction of
Incorporation
|
|
Monopar
Therapeutics Australia Ltd Pty
|
|
Monopar
Therapeutics Inc.
|
|
100%
|
|
Australia
|
|
Monopar
Therapeutics, SARL
|
|
Monopar
Therapeutics Inc.
|
|
100%
|
|
France
|